olevaprubart — Topline data
Q4 2027
Topline data from the study is anticipated in the fourth quarter of 2027.Source filing
IMA biotech catalysts & pipeline
IMAGENEBIO INC · Data as of 2026-09-08
Upcoming catalysts
olevaprubart — Initial data
in 2028
Initial data expected in 2028, leveraging the clinical operations and investigator network the Company has developed through its atopic dermatitis program.Source filing
olevaprubart — Conference presentation
Sep 30–Oct 3
Imagene will present two posters at the 2026 European Academy of Dermatology and Venereology (EADV) Congress:Source filing